What Dandelion Health does
Dandelion Health provides an AI-driven data platform that combines structured clinical records and claims data with unstructured raw biological signals, including ECG waveforms, echocardiogram videos, radiology imaging, pulmonary function tests, and ultrasound data, to support pharmaceutical and life sciences research. The company says its multimodal data infrastructure spans 73 hospitals, more than 15 million patients, and eight petabytes of data, and is used to accelerate drug development, deepen pharma partnerships, and support AI model development. Dandelion Health was founded in 2020 by Elliott Green, Ziad Obermeyer, and Sendhil Mullainathan and is headquartered in New York.
Dandelion Health is a research tool on Falcoscan. Multimodal real-world clinical data platform for pharmaceutical R&D. Falcoscan rates Dandelion Health with an Opportunity score of 78/100, a Saturation score of 14/100, and a Wrapper-risk score of 15/100. Market signal: rising. Dandelion Health is founded in 2020, currently at Series_a stage. Pricing: Paid.